Justin T. Ernst,Paul A. Sprengeler,Siegfried H. Reich,Samuel Sperry
申请号：
US16233507
公开号：
US20190275039A1
申请日:
2018.12.27
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula (I):or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof wherein X1, X2, R1, R2, R3 and n are as defined herein. Also described are pharmaceutically acceptable compositions of Formula (I) compounds as well as methods for utilizing the compounds of Formula (I) and the pharmaceutically acceptable compositions of Formula (I) compounds as inhibitors of Mnk as well as therapeutics for the treatment of diseases such as cancer.
